Lataz

Latanoprost, the active ingredient in Lataz, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is indicated for primary open‑angle glaucoma and ocular hypertension in adult patients. It is used under the supervision of an eye care professional.

GNH USA supplies Lataz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets. The company adheres to stringent manufacturing standards and provides reliable logistics for global distribution.

Lataz (latanoprost) is a prostaglandin analog used to manage conditions involving elevated intra‑ocular pressure.

- Primary open‑angle glaucoma: reduces intra‑ocular pressure, helping to prevent optic nerve damage. - Ocular hypertension: lowers eye pressure to reduce the risk of progression to glaucoma. - Glaucoma (any type): contributes to intra‑ocular pressure reduction as part of a comprehensive treatment plan.

Lataz may cause ocular and systemic reactions. Patients should be aware of both frequent and less common events.

Common Side Effects: - Conjunctival hyperemia: redness of the eye. - Increased eyelash growth: longer, thicker lashes. - Iris pigmentation change: darkening of eye color. - Eye irritation or foreign‑body sensation. - Blurred vision: temporary visual disturbance. - Periorbital skin darkening.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, itching, or rash. - Ocular inflammation: uveitis or iritis. - Paradoxical increase in intra‑ocular pressure. - Corneal edema: swelling of the cornea. - Macular edema: fluid accumulation in the retina. - Vision loss: sudden decrease in visual acuity.

Before initiating therapy, clinicians should evaluate patient history and monitor ocular health. - Pregnancy: discuss potential risks with a healthcare professional before use. - Breastfeeding: consider benefits versus potential exposure to the infant. - Hypersensitivity: avoid if the patient has known allergy to latanoprost or formulation components. - Regular monitoring: schedule periodic intra‑ocular pressure checks and eye examinations. - Contact lens wear: advise removal before instillation and allow drops to dry before reinserting lenses. - Store at room temperature: keep in the original container, protect from light and moisture.

Lataz can interact with other ocular or systemic agents; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Concurrent use of another prostaglandin analog: may cause additive pressure‑lowering effects and increase side‑effect risk. - Recent ocular surgery: avoid until the eye has fully healed to prevent interference with wound healing. - Contact lens use with contaminated drops: may lead to infection.

Moderate Interactions (Monitor Closely):\n- Beta‑blocker eye drops: monitor intra‑ocular pressure for excessive reduction. - Carbonic anhydrase inhibitor eye drops: watch for additive pressure‑lowering effect. - Systemic carbonic anhydrase inhibitors: adjust monitoring of intra‑ocular pressure as needed.